Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Uricase or homologous enzyme thereof as well as application of uricase or homologous enzyme

A technology of uricase and uric acid, which is applied in the field of biomedicine, can solve the problem of no further treatment plan, and achieve the effect of good colonization ability

Active Publication Date: 2020-10-16
成都薇合生物科技有限公司
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For this subset of patients with poor renal function, no further treatment options are currently available

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Uricase or homologous enzyme thereof as well as application of uricase or homologous enzyme
  • Uricase or homologous enzyme thereof as well as application of uricase or homologous enzyme
  • Uricase or homologous enzyme thereof as well as application of uricase or homologous enzyme

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Rat hyperuricemia model was established by adding 5% potassium oxycyanate (Chengdu Dashuo Experimental Animal Co., Ltd.) to common rat diet for 2 weeks (references Lu, J., et al., Mouse models for humanhyperuricaemia: a critical review.Nature reviews.Rheumatology,2019.15(7):p.413-426.), in the 2-week experimental cycle, before starting the experiment, first use streptomycin containing 2mg / mL and 1 mg / mL of ampicillin in sterile drinking water fed rats (initial body weight of 120g-150g, Chengdu Dashuo Experimental Animal Co., Ltd., divided into 6 groups. Except for the 1-day group, the initial number of each group was 6 7 rats in the 1-day group) for three days, and then fed with normal sterile water for one day, then 1 day / time, 3 days / time, 5 days / time or 7 days / time, including 2×10 10 cfu Escherichia coli Nissle 1917 was administered with normal saline (about 200 μL), and the hyperuricemia group was administered with 0.2 mL of normal saline at a frequency of 1 day / tim...

Embodiment 2

[0088] In the rat hyperuricemia model established by adding 5% potassium oxycyanate (Chengdu Dashuo Experimental Animal Co., Ltd.) to the common rat diet for 2 weeks, in the 2-week experimental period, before starting the experiment Rats were first fed with sterile drinking water containing 2mg / mL streptomycin and 1mg / mL ampicillin (the initial body weight was 120g-150g, Chengdu Dashuo Experimental Animal Co., Ltd., divided into 6 groups. Each group The initial number was 6) for three days, and then fed with ordinary sterile water for one day, the allopurinol group was given 1.2mg / 100g high-intensity allopurinol by gavage at a frequency of 3 days / time (equivalent to In the sum of the upper limit of the human dose of allopurinol for 3 days and one-time administration), the Escherichia coli Nissle 1917 group was carried out at a frequency of 3 days / time containing 2×10 10 cfu Escherichia coli Nissle 1917 was intragastrically administered with normal saline (about 200 μL), and th...

Embodiment 3

[0092] The names and sequences of the two FAD-dependent urate oxidase and glutamate synthetase are:

[0093] ygfT: as shown in SEQ ID No.1

[0094] MNKFIAAEAA ECIGCHACEI ACAVAHNQEN WPLSHSDFRP RIHVVGKGQAANPVACHHCNNAPCVTACPV NALTFQSDSV QLDEQKCIGC KRCAIACPFGVVEMVDTIAQ KCDLCNQRSS GTQACI D VCPTQALRLMDDKGLQQIKVARQRKTAAGKASSDAQPSRSAALLPVNSRKGADKISASERKTHFGEIYCGLDPQQATYESDRCVYCAEKANCNWHCPLHNAIPDYIRLVQEGKIIEAAELCHQTSSLPEICGRVCPQDRLCEGACTLKDHSGAVSIGNLERYITDTALAMGWRPDVSKVVPRSEKVAVIGAGPAGLGCADILARAGVQVDVFDRHPEIGGMLTFGIPPFKLDKTVLSQRREIFTAMGIDFHLNCEIGRDISFNELTAEYDAVFLGVGTYGMMRADLPHEDAPGVIQALPFLTAHTRQLMGLPESAEYPLTDVEGKRVVVLGGGDTTMDCLRTSIRLNAASVTCAYRRDEVSMPGSRKEVVNAREEGVEFQFNVQPQYIACDEDGRLTAVGLIRTAMGEPGPDGRRRPRPVAGSEFELPADVLIMAFGFQAHTMPWLQGSGIKLDKWGLIQTGDVGYLPTQTHLKKVFAGGDAVHGADLVVTAMAAGRQAARDMLTLFDTKAS*

[0095] AegA: as shown in SEQ ID No.2

[0096] MNRFIMANSQ QC L GCHACE I ACVMAHNDEQ HVLS QH HFHPRITVIKHQQQRSAVTCHHCEDAPCARSCPNGAISHVDDSIQVNQQKCIGCKSCVVACPFGTMQIVLTPVAVGKVKATAHKCDLCAGREN...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the field of biomedicine, in particular to uricase or a homologous enzyme thereof as well as application of the uricase or the homologous enzyme. Through experiments,it is found that Escherichia coli Nissle 1917, which contains a novel non-homologous isomeric FAD-dependent urate oxidase, can be administered in a hyperuricemia rat model at a frequency of 3-5 days,and can still has ab effect of reducing blood uric acid of the rat model. The Escherichia coli Nissle 1917 is used, the purpose of using non-existing drug principles and avoiding daily use to alleviate hyperuricemia is achieved. The results show that Escherichia coli Nissle 1917 can be used for treating patients with hyperuricemia and gout.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to uricase or its homologous enzyme and application thereof. Background technique [0002] Hyperuricemia refers to a state of elevated uric acid in the blood, which is defined as a serum uric acid greater than 6.8 or 7.0 mg / dL. Long-term hyperuricemia can lead to gout. In recent years, it has been found that asymptomatic hyperuricemia may increase the risk of many diseases, such as cardiovascular disease and metabolic syndrome. These potential health problems have caused a heavy social medical burden. Therefore, hyperuricemia has received more and more attention in recent years. People with mild hyperuricemia can generally reduce their uric acid levels by controlling diet, losing weight, and changing lifestyle. However, many people with hyperuricemia are difficult to meet the above requirements because the state does not cause any disease manifestations. In this case, whether to use d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/06C12N15/53A61K38/44A61K35/74A61P19/06
CPCA61K35/74A61K38/44A61P19/06C12N9/0048C12Y107/03003A61K2300/00Y02A50/30
Inventor 罗云孜余泓彬赵启元祝洁杨斌
Owner 成都薇合生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com